223 related articles for article (PubMed ID: 7797599)
1. Effects of pravastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, on two human tumour cell lines.
Gebhardt A; Niendorf A
J Cancer Res Clin Oncol; 1995; 121(6):343-9. PubMed ID: 7797599
[TBL] [Abstract][Full Text] [Related]
2. Relative induction of mRNA for HMG CoA reductase and LDL receptor by five different HMG-CoA reductase inhibitors in cultured human cells.
Morikawa S; Umetani M; Nakagawa S; Yamazaki H; Suganami H; Inoue K; Kitahara M; Hamakubo T; Kodama T; Saito Y
J Atheroscler Thromb; 2000; 7(3):138-44. PubMed ID: 11480454
[TBL] [Abstract][Full Text] [Related]
3. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase.
Cohen LH; van Vliet A; Roodenburg L; Jansen LM; Griffioen M
Biochem Pharmacol; 1993 Jun; 45(11):2203-8. PubMed ID: 8517861
[TBL] [Abstract][Full Text] [Related]
4. Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver.
Powell EE; Kroon PA
J Clin Invest; 1994 May; 93(5):2168-74. PubMed ID: 8182149
[TBL] [Abstract][Full Text] [Related]
5. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
Lennernäs H; Fager G
Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
[TBL] [Abstract][Full Text] [Related]
7. Overaccumulation of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase in a compactin(ML-236B)-resistant mouse cell line with defects in the regulation of its activity.
Hasumi K; Yamada A; Shimizu Y; Endo A
Eur J Biochem; 1987 May; 164(3):547-52. PubMed ID: 3569277
[TBL] [Abstract][Full Text] [Related]
8. Regulation of porcine granulosa cell 3-hydroxy-3-methylglutaryl coenzyme A reductase by insulin and insulin-like growth factor I: synergism with follicle-stimulating hormone or protein kinase A agonist.
Maitra A; LaVoie HA; Day RN; Garmey JC; Veldhuis JD
Endocrinology; 1995 Nov; 136(11):5111-7. PubMed ID: 7588248
[TBL] [Abstract][Full Text] [Related]
9. Abnormal regulation of the LDL-R and HMG CoA reductase genes in subjects with familial hypercholesterolemia with the "French Canadian mutation".
Yu L; Qiu S; Genest J
Atherosclerosis; 1996 Jul; 124(1):103-17. PubMed ID: 8800498
[TBL] [Abstract][Full Text] [Related]
10. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes.
Qin W; Infante J; Wang SR; Infante R
Biochim Biophys Acta; 1992 Jul; 1127(1):57-66. PubMed ID: 1627634
[TBL] [Abstract][Full Text] [Related]
11. Effects of propionic acid and pravastatin on HMG-CoA reductase activity in relation to forestomach lesions in the rat.
Bueld JE; Bannenberg G; Netter KJ
Pharmacol Toxicol; 1996 Apr; 78(4):229-34. PubMed ID: 8861780
[TBL] [Abstract][Full Text] [Related]
12. IL-6 is a key factor in growth inhibition of human myeloma cells induced by pravastatin, an HMG-CoA reductase inhibitor.
Otsuki T; Sakaguchi H; Eto M; Fujii T; Hatayama T; Takata A; Tsujioka T; Sugihara T; Hyodoh F
Int J Oncol; 2003 Sep; 23(3):763-8. PubMed ID: 12888915
[TBL] [Abstract][Full Text] [Related]
13. In-vitro effect of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors on non-hepatic LDL receptor activity: evidence of lack of stimulatory effect of pravastatin.
Pedreño J; Sánchez JL; Zambón D; Ros E
Coron Artery Dis; 1994 Dec; 5(12):971-7. PubMed ID: 7728297
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of the expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase, synthase, and low density lipoprotein receptor genes.
Cuthbert JA; Lipsky PE
J Lipid Res; 1992 Aug; 33(8):1157-63. PubMed ID: 1358996
[TBL] [Abstract][Full Text] [Related]
15. Effects of pravastatin on the expression of ATP-binding cassette transporter A1.
Ando H; Tsuruoka S; Yamamoto H; Takamura T; Kaneko S; Fujimura A
J Pharmacol Exp Ther; 2004 Oct; 311(1):420-5. PubMed ID: 15210833
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin impairs mitogen-induced proliferation of malignant B-lymphocytes from humans--in vitro and in vivo studies.
Vitols S; Angelin B; Juliusson G
Lipids; 1997 Mar; 32(3):255-62. PubMed ID: 9076662
[TBL] [Abstract][Full Text] [Related]
17. Effect of pravastatin on type IV collagen secretion and mesangial cell proliferation.
Nishimura M; Tanaka T; Yasuda T; Kurakata S; Kitagawa M; Yamada K; Saito Y; Hirai A
Kidney Int Suppl; 1999 Jul; 71():S97-100. PubMed ID: 10412748
[TBL] [Abstract][Full Text] [Related]
18. HMG-CoA reductase inhibitors suppress macrophage growth induced by oxidized low density lipoprotein.
Sakai M; Kobori S; Matsumura T; Biwa T; Sato Y; Takemura T; Hakamata H; Horiuchi S; Shichiri M
Atherosclerosis; 1997 Aug; 133(1):51-9. PubMed ID: 9258407
[TBL] [Abstract][Full Text] [Related]
19. Co-ordinate regulation of low-density-lipoprotein receptor and 3-hydroxy-3-methylglutaryl-CoA reductase and synthase gene expression in HepG2 cells.
Molowa DT; Cimis GM
Biochem J; 1989 Jun; 260(3):731-6. PubMed ID: 2569863
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of cells resistant to ML236B (compactin) with increased levels of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Ryan J; Hardeman EC; Endo A; Simoni RD
J Biol Chem; 1981 Jul; 256(13):6762-8. PubMed ID: 7240242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
